How finasteride treats male pattern hair loss

How finasteride works on hair loss

Finasteride is a 5-alpha reductase inhibitor. It blocks the enzyme that converts testosterone into dihydrotestosterone (DHT), the hormone most responsible for shrinking, or 'miniaturizing,' genetically susceptible hair follicles on the scalp over time in men with androgenetic alopecia (male pattern hair loss). Lowering scalp DHT does not regrow hair follicles that have already been permanently lost, but it can slow further miniaturization and, in many men, increase hair count and thickness in follicles that are still active.

Finasteride does not work on other causes of hair loss, such as alopecia areata, telogen effluvium, or scarring alopecia. A licensed provider distinguishes between these before deciding whether finasteride is an appropriate treatment.

FDA-labeled dosing for hair loss

The FDA label for finasteride 1 mg (brand name Propecia) calls for one tablet taken once daily, with or without food. That is the entire labeled regimen for male pattern hair loss - there is no titration schedule or as-needed use, unlike some of the ED medications covered elsewhere in this library.

It's worth being precise about strength: finasteride is also sold at a 5 mg dose (brand name Proscar) for benign prostatic hyperplasia (an enlarged prostate), an entirely different labeled indication. The 1 mg hair-loss dose and the 5 mg BPH dose are not interchangeable, and taking the higher-strength tablet for hair loss is not a labeled use.

• 1 mg once daily: the complete FDA-labeled dose for male pattern hair loss
• Taken with or without food, at roughly the same time each day
• Not labeled for use in women or in men under 18

Realistic timeline and what clinical trials found

The FDA label states that daily use for three months or more is necessary before any benefit is observed, and that response is typically judged over about 12 months of continuous, uninterrupted use. If an area shows no improvement by then, the label notes further treatment is unlikely to help. Stopping finasteride reverses its effect: the label describes a reversal of effect within about 12 months of discontinuation, meaning any gained hair is not permanently retained once the medication is stopped.

The pivotal trial (Kaufman et al., 1998) followed 1,553 men aged 18 to 41 with mild to moderate vertex hair loss on finasteride 1 mg versus placebo for one year, with 1,215 continuing into a second blinded year. In the FDA label's summary of these studies, 65 percent of men on finasteride showed increased hair growth by investigator assessment at 12 months, versus 37 percent on placebo, with a hair-count difference favoring finasteride of about 107 hairs in a defined scalp area. By 24 months, 80 percent of men on finasteride showed increased hair growth versus 47 percent on placebo, with about a 138-hair difference. These are group averages from clinical trials, not a personal forecast for any individual.

What Beema's finasteride offers, and how it's different

Beema's oral finasteride is the FDA-approved generic version of Propecia: the identical active ingredient, strength, and intended use as the brand-name product, dispensed by a licensed pharmacy - not a compounded formulation. That makes it different from most other products in this learn library, where Beema's live offering is a compounded, non-FDA-approved formulation.

A licensed provider reviews each patient's intake, including hair loss pattern and health history, and independently decides whether finasteride may be appropriate; completing intake does not guarantee a prescription. See the oral finasteride page for pricing and eligibility.

Safety basics this article will not skip

In the 12-month PROPECIA trials, the most commonly reported drug-related adverse reactions were decreased libido, erectile dysfunction, and ejaculation disorder, each occurring in roughly 1 to 2 percent of men, versus a lower rate on placebo; about 3.8 percent of men on finasteride reported at least one such reaction. Sexual side effects generally resolved in men who stopped the medication, but the label also references postmarketing reports describing sexual dysfunction that continued after treatment was discontinued. This is a real risk to weigh with a licensed provider, not a footnote to skip.

Finasteride lowers serum PSA (prostate-specific antigen), roughly by about a third at the 1 mg dose in clinical studies, which matters if you are also being screened for prostate cancer - any confirmed rise from your lowest on-treatment PSA value should still be evaluated. Labeling for 5-alpha reductase inhibitors as a class also references a possible increased risk of high-grade prostate cancer, based on findings from larger trials at the higher 5 mg dose. Women who are or may become pregnant should not handle crushed or broken tablets because of the risk finasteride poses to a male fetus's genital development; intact tablets are film-coated to prevent contact during normal handling.

Frequently asked questions

Sources

1. [1] PROPECIA (finasteride) 1 mg tablets, FDA-approved prescribing information via DailyMed.
2. [2] MedlinePlus. Finasteride: drug information.
3. [3] Kaufman KD, et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Journal of the American Academy of Dermatology. 1998.